CRG recruits Whitehead as investor relations VP

CRG has named Adam Whitehead as vice president of investor relations. Previously, Whitehead worked at Crestone Capital Advisors where he served as a senior investment analyst.


HOUSTON, Oct. 19, 2016 /PRNewswire/ — CRG, a global healthcare-focused investment firm supporting innovative healthcare companies, announced today the appointment of Adam Whitehead as Vice President of Investor Relations in the firm’s Boulder office. Mr. Whitehead will help build and manage relationships with CRG’s limited partners and expand the firm’s investor relations strategy. Mr. Whitehead will report to Mike Weinmann, Managing Director at CRG.

Mr. Whitehead brings to CRG more than 10 years of experience in asset allocation, manager due diligence and fundraising, and established relationships with institutional investors. Previously, Mr. Whitehead spent six years as a senior investment analyst at Crestone Capital Advisors, a large multi-family office for ultra-high net worth entrepreneurs and executives. He also served as Vice President of Research for Sovereign Wealth Management. In addition, Mr. Whitehead served as Vice President of Research for Quantitative Equity Systems; Director of Research at The Bornhoft Group; and Principal and Director of Trading and Research at Warwick Capital Management. He began his investment career as a Proprietary Trader and Asset/Liability Modeler at Branch Banking & Trust.

Mr. Whitehead graduated from Saint Andrews Presbyterian College, magna cum laude, in Laurinburg, North Carolina with a double major in business (emphasis in finance and accounting).

“Adam brings to CRG deep knowledge of the alternative investment landscape and a strong book of contacts to continue our rapid growth,” said Nate Hukill, President of CRG. “This exciting addition will help us better service our limited partners and expand on relationships with institutional investors that allocate to private capital investment strategies.”

About CRG

Founded in 2003, CRG (previously known as Capital Royalty L.P.) is a healthcare-focused investment firm that delivers pioneering growth capital financing solutions to the global healthcare industry. With nearly $3.0 billion of assets under management across 42 healthcare investments, CRG provides growth capital to healthcare companies primarily through structured debt and senior secured loans. CRG works across the spectrum of healthcare products, technologies and services and targets investment sizes ranging between $20 million and $300 million. The firm partners with innovative, commercial-stage healthcare companies that address large, unmet medical needs who are seeking flexible financing solutions with a committed, value-add partner to achieve their growth objectives. CRG is headquartered in Houston, Texas with offices in Boulder, Colorado and New York. For additional information, please visit